Stock listing

NYSE American:AZTR Azitra Inc Stock

Home listing (NYSE American) of Azitra Inc

Follow Azitra Inc into a list and get an email when it puts out news.

Share price · AMEX:AZTR

$0.517 USD -0.053 (-9.4%)

Close on Nov 20, 2026

Past year -83.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.509 – $0.552 USDNov 20, 2026
Volume
56,165 sharesNov 20, 2026
Market cap
$3.13M USDAt the close on Nov 20, 2026 · price × 6.06M shares outstanding
52-week range
$0.509 – $3.910 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$3.73M USDMedian day 8,258 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Azitra Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE American:AZTR · Home$0.517 USD-0.053 (-9.4%)56,165$0.541$0.552$0.509$0.570Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · AMEX:AZTR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.517-0.053-9.4%$0.541$0.552$0.50956,165
$0.570-0.038-6.2%$0.587$0.605$0.57027,830
$0.608-0.019-3.0%$0.627$0.627$0.58431,780
$0.627+0.019+3.1%$0.597$0.652$0.560160,378
$0.608-0.060-9.0%$0.660$0.670$0.60877,105
$0.669+0.083+14.2%$0.566$0.690$0.561215,847
$0.585-0.015-2.5%$0.600$0.619$0.58568,841
$0.600-0.044-6.8%$0.665$0.690$0.600149,079
$0.644-0.089-12.1%$0.724$0.724$0.644190,125
$0.733+0.007+1.0%$0.749$0.780$0.71995,558
$0.725-0.091-11.1%$0.800$0.811$0.710176,795
$0.816-0.068-7.7%$0.857$0.857$0.795133,783
$0.884+0.047+5.7%$0.792$0.950$0.780337,873
$0.836+0.067+8.8%$0.769$0.900$0.740522,730
$0.769+0.012+1.6%$0.712$0.790$0.651783,000
$0.757-0.148-16.4%$0.863$0.873$0.7321,128,700
$0.905-0.215-19.2%$1.090$1.110$0.8602,687,700
$1.120-0.410-26.8%$1.210$1.320$1.0507,835,100
$1.530+0.810+112.5%$1.040$2.130$0.906148,420,100
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.7200.0000.0%$0.720$0.720$0.7200
$0.720-0.460-39.0%$1.210$1.210$0.52026,706
$1.180-0.120-9.2%$1.300$1.320$1.1604,721
$1.300-0.020-1.5%$1.300$1.320$1.2603,230
$1.3200.0000.0%$1.330$1.350$1.3002,871
$1.320+0.020+1.5%$1.330$1.370$1.3002,892
$1.300-0.070-5.1%$1.400$1.400$1.3004,128
$1.370+0.050+3.8%$1.380$1.400$1.3006,229
$1.320+0.030+2.3%$1.340$1.380$1.3008,258
$1.290-0.090-6.5%$1.390$1.470$1.23014,292
$1.380+0.070+5.3%$1.340$1.390$1.3206,087
$1.310-0.390-22.9%$1.640$1.670$1.24032,145
$1.700+0.020+1.2%$1.700$1.750$1.6306,110
$1.680+0.010+0.6%$1.610$1.690$1.6101,525
$1.670+0.010+0.6%$1.660$1.680$1.5906,060
$1.660-0.050-2.9%$1.700$1.750$1.6508,495
$1.7100.0000.0%$1.720$1.740$1.6602,965
$1.710-0.030-1.7%$1.770$1.770$1.6706,200
$1.740-0.040-2.2%$1.810$1.810$1.70011,201
$1.780+0.160+9.9%$1.620$1.800$1.6205,677
$1.620-0.090-5.3%$1.760$1.760$1.61011,244
$1.710-0.050-2.8%$1.780$1.790$1.7104,702
$1.760-0.020-1.1%$1.850$1.910$1.76013,020
$1.780-0.020-1.1%$1.820$1.850$1.7702,910
$1.800+0.020+1.1%$1.780$1.880$1.7305,701
$1.780+0.060+3.5%$1.710$1.830$1.6905,995
$1.720-0.080-4.4%$1.750$1.790$1.7202,860
$1.8000.0000.0%$1.780$1.800$1.7003,303
$1.800-0.010-0.6%$1.760$1.820$1.7503,004
$1.810+0.040+2.3%$1.710$1.830$1.6905,274
$1.770+0.020+1.1%$1.730$1.780$1.7103,702
$1.750-0.020-1.1%$1.730$1.770$1.6906,441
$1.770-0.090-4.8%$1.820$1.890$1.71010,319
$1.860+0.130+7.5%$1.740$1.890$1.65024,337
$1.730+0.150+9.5%$1.570$1.840$1.53051,083
$1.580+0.080+5.3%$1.590$1.650$1.47049,156
$1.500+0.170+12.8%$1.320$1.600$1.280277,254
$1.330+0.060+4.7%$1.350$1.410$1.30020,003
$1.270+0.020+1.6%$1.300$1.300$1.2604,784

Splits

3 splits since 2024 · AMEX:AZTR · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
3-for-20Consolidation
1-for-30Consolidation
Ticker
NYSE American:AZTR
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NYSE American
Currency
USD

What changed lately

Latest news

All Azitra Inc news

Azitra Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
23 in the last 12 months · 39 in all · newest Nov 12, 2026 · oldest 2025
Decks
4 decks · latest August 2026

Where Azitra Inc is listed

ListingExchangeCountryCurrency
NYSE American:AZTR · Home listing · This pageNYSE AmericanUnited StatesUSD
BOATS:AZTRBOATSUnited StatesUSD

Valuation

Price/book 0.7× against a median of 0.6×: 5th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$618,677 USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.7×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.60

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Azitra Inc · AMEX:AZTRUS$3.13M−US$618,677n/an/an/a0.7×n/a0.0×0.60
Xenetic Biosciences, Inc. · NASDAQ:XBIOUS$3.28M−US$2.53Mn/a−0.8×n/a0.7×−123.7%0.0×1.46
Aprea Therapeutics, Inc. · NASDAQ:APREUS$3.25M−US$34.60Mn/an/an/a0.1×n/a0.0×0.73
Spago Nanomedical AB · OMXSTO:SPAGOUS$3.20MUS$22,063n/a5.6×n/a1.0×n/a0.0×n/a
Kiora Pharmaceuticals, Inc. · NASDAQ:KPRXUS$3.19M−US$12.81Mn/a−12.8×n/a0.2×n/a0.0×1.54
NuCana plc · NASDAQ:NCNAUS$3.12M−US$21.37Mn/an/an/a0.1×n/a0.0×1.58
Revive Therapeutics Ltd. · CSE:RVVUS$3.10MUS$3.14Mn/an/an/an/an/an/a0.56
Skye Bioscience, Inc. · NASDAQ:SKYEUS$3.10M−US$1.71Mn/an/an/a2.3×n/a0.0×0.85
Creative Medical Technology Holdings, Inc. · NASDAQ:CELZUS$3.06M−US$3.79Mn/a−1,263×n/a0.4×n/a0.0×1.53
Oncology Pharma Inc. · OTC:ONPHUS$3.04Mn/an/an/an/an/an/an/a1.62
Imunon, Inc. · NASDAQ:IMNNUS$3.00MUS$5.90Mn/an/an/a1.1×n/a2.6×0.57
Median of the othersUS$3.11M−US$2.53M−6.8×0.6×−123.7%0.0×1.46

Forecasts

1 buy · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
3.50 USD · Analysts' mean
EPS, year to Dec 2026
-2.05 · 1 analyst

Team and board

Officers

OfficerRole
Francisco SalvaPresident and CEO
Norman StaskeyChief Financial Officer
Travis WhitfillCofounder and Chief Operating Officer

Board

DirectorRole
Francisco SalvaPresident and CEO
John R. SchroerDirector
Travis WhitfillCofounder and Chief Operating Officer

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close−9.0%
Q2 2026Aug 12, 2026−2.1%
Q1 2026May 13, 2026−15.9%
Q4 2025Feb 27, 2026 · After close−6.3%
Q3 2025Nov 12, 2025 · After close−14.6%
Q2 2025Aug 11, 2025 · After close−7.5%
Q1 2025May 14, 2025+0.4%
Q4 2024Feb 24, 2025 · Before open−4.3%
Q3 2024Nov 12, 2024 · After close−3.7%
Q2 2024Aug 12, 2024 · After close+2.9%
All 13 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−13.3%
Q4 2023Mar 15, 2024 · After close0.0%
Q3 2023Nov 14, 2023 · After close−3.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck30 slidesAugust 2026
Technical Presentation (2024)Technical18 slides2024
Investor Presentation (July 2023)Investor deck26 slidesJul 7, 2023
Society of Investigative Dermatology Annual MeetingConference16 slides

Open Decks

Financings

RaiseDate
Private placement of shares of common stock underlying warrants
Update: about US$1.5M · US$0.32 a share · Warrants at US$0.32 for 60 months · Maxim Group LLC
Dealers: Maxim Group LLC (lead)
Buyers: Alumni Capital LP
Feb 6, 2026
Common stock (equity line of credit)
Tranche closed: US$2.8M raised
Buyers: Alumni Capital LP ($2.8M in gross proceeds through the equity line of credit)
Use of proceeds: To fund the clinical pipeline
Nov 12, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$5.00 a share on Jun 15, 2023.

Price
US$5.00 a share
Shares offered
1,500,000 shares of common stock
Offering size
US$7.5 million
Underwriters' option
Up to 225,000 more shares
Listing
AZTR on NYSE American
Underwriter
ThinkEquity
Shares delivered
On or about Jun 21, 2023

Steps

StepWhen
Draft sent to the SEC in confidenceDec 15, 2022
Filed publiclyFeb 21, 2023
Amended 6 timesNewest Jun 13, 2023
Shares registered with an exchangeMay 16, 2023
Declared effective by the SECJun 15, 2023
Final prospectus, with the priceJun 21, 2023

Filings

FilingFiled
424B4 · ProspectusJun 21, 2023
EFFECT · Notice that a registration is effectiveJun 15, 2023
CORRESP · Letter to the SECJun 13, 2023
S-1/A · Registration statement, amendedJun 13, 2023
CORRESP · Letter to the SECJun 13, 2023
CORRESP · Letter to the SECJun 13, 2023
UPLOAD · Letter from the SECJun 13, 2023
FWP · Free writing prospectusJun 5, 2023
S-1/A · Registration statement, amendedJun 5, 2023
CORRESP · Letter to the SECMay 31, 2023
All 35 filings
FilingFiled
CORRESP · Letter to the SECMay 30, 2023
CORRESP · Letter to the SECMay 30, 2023
CORRESP · Letter to the SECMay 26, 2023
CORRESP · Letter to the SECMay 22, 2023
CORRESP · Letter to the SECMay 22, 2023
CORRESP · Letter to the SECMay 17, 2023
CERT · Exchange's certificate of listingMay 17, 2023
S-1/A · Registration statement, amendedMay 16, 2023
8-A12B · Registration of shares for listing on an exchangeMay 16, 2023
CORRESP · Letter to the SECMay 15, 2023
CORRESP · Letter to the SECMay 15, 2023
S-1/A · Registration statement, amendedMay 9, 2023
FWP · Free writing prospectusApr 28, 2023
FWP · Free writing prospectusApr 11, 2023
CORRESP · Letter to the SECApr 10, 2023
S-1/A · Registration statement, amendedApr 10, 2023
UPLOAD · Letter from the SECApr 3, 2023
FWP · Free writing prospectusMar 27, 2023
CORRESP · Letter to the SECMar 20, 2023
S-1/A · Registration statement, amendedMar 20, 2023
UPLOAD · Letter from the SECMar 10, 2023
CORRESP · Letter to the SECFeb 21, 2023
S-1 · Registration statementFeb 21, 2023
UPLOAD · Letter from the SECJan 16, 2023
DRS · Draft registration statementDec 15, 2022

Open IPO · From the cover of the final prospectus (424B4) filed Jun 21, 2023

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue07.50K686.0K284.0K110.0K
Cost of revenue453.1K448.2K425.5K406.0K84.8K
Gross profit-453.1K7.50K686.0K284.0K110.0K
Research and development4.84M4.72M3.64M6.10M5.38M
Selling, general and administrative6.13M6.27M4.49M3.64M3.95M
Operating income-11.0M-11.0M-7.45M-9.45M-9.22M
Depreciation and amortization138.1K131.2K129.7K125.9K84.8K57.0K
EBITDA-10.8M-10.9M-7.32M-9.33M-9.14M
Interest expense7.59K12.2K167.7K251.9K67.0K
Income before tax-10.9M-8.96M-11.3M-10.7M-8.94M
Income tax8.32K9.03K17.3K-727.8K174.4K
Net income-11.0M-8.97M-11.3M-10.7M-8.94M
Earnings per share, basic-2.25-15.70-54.98-12.74-147.78
Earnings per share, diluted-2.25-15.70-54.98-12.74

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents2.07M4.55M1.80M3.49M8.04M
Short-term investments-4.55B
Receivables912233223.5K175.0K334.2K528.4K
Inventory-215.2K216.9K
Current assets3.02M5.23M2.54M4.14M8.49M16.6M
Property, plant and equipment548.6K654.0K710.1K847.0K946.7K582.4K
Goodwill246.2M
Total assets5.03M7.36M5.12M7.17M10.2M
Accounts payable399.4K490.3K897.3K784.7K717.8K417.4K
Current liabilities1.07M1.38M1.60M2.22M1.21M1.00M
Long-term debt6.60M992.0K
Total debt422.1K555.5K885.9K7.73M992.0K
Total liabilities1.22M1.66M2.20M9.73M36.0M
Shareholders' equity3.80M5.70M2.91M-36.3M-25.8M
Shares outstanding1.07M1.15M403.2K1.04M60.5K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-11.2M-10.2M-7.36M-8.35M-8.07M-6.54M
Capital spending-24.2K-8.57K-26.5K-33.1K-652.3K-217.7K
Free cash flow-11.2M-10.2M-7.39M-8.38M-8.72M-6.76M
Cash from investing-182.9K-379.2K-318.3K-336.8K-652.3K-541.0K
Cash from financing8.92M13.3M5.98M4.13M992.9K16.6M
Change in cash-2.49M2.76M-1.70M-4.55M-7.73M9.47M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13D · Big-stake noticeNov 16, 2026Big-stake noticeSEC
8-K · Current reportNov 12, 2026ResultsSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2026Big-stake noticeSEC
8-K · Current reportNov 10, 2026Current reportSEC
8-K · Current reportOct 29, 2026Current reportSEC
8-K · Current reportOct 26, 2026Current reportSEC
8-K · Current reportOct 22, 2026Current reportSEC
8-K · Current reportOct 1, 2026Current reportSEC
8-K · Current reportSep 28, 2026Material contractSEC
Show 200 filings
FilingDateTypeFiled with
424B5 · ProspectusSep 28, 2026Offer documentSEC
8-K · Current reportSep 8, 2026Current reportSEC
8-K · Current reportAug 21, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
8-K · Current reportAug 12, 2026ResultsSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
8-K · Current reportJul 15, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeJun 25, 2026Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeJun 24, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJun 22, 2026Big-stake noticeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
8-K · Current reportJun 17, 2026Current reportSEC
8-K · Current reportJun 16, 2026Meeting outcomeSEC
DEFA14A · Additional proxy materialJun 4, 2026Meeting noticeSEC
8-K · Current reportJun 4, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveJun 3, 2026Other filingsSEC
CORRESP · Letter to the SECMay 29, 2026Other filingsSEC
DEFA14A · Additional proxy materialMay 27, 2026Meeting noticeSEC
8-K · Current reportMay 27, 2026Current reportSEC
UPLOAD · Letter from the SECMay 27, 2026Other filingsSEC
S-1 · Registration statementMay 21, 2026Offer documentSEC
8-K · Current reportMay 12, 2026ResultsSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
ARS · Annual report to shareholdersMay 8, 2026Annual reportSEC
DEF 14A · Proxy statementMay 8, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 27, 2026Meeting noticeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
8-K · Current reportMar 23, 2026Material contractSEC
4 · Change in ownershipMar 20, 2026Insider tradeSEC
8-K · Current reportMar 13, 2026Current reportSEC
DEFA14A · Additional proxy materialMar 5, 2026Meeting noticeSEC
8-K · Current reportMar 5, 2026Current reportSEC
8-K · Current reportFeb 27, 2026ResultsSEC
10-K · Annual reportFeb 27, 2026Annual reportSEC
DEFA14A · Additional proxy materialFeb 6, 2026Meeting noticeSEC
8-K · Current reportFeb 6, 2026Current reportSEC
S-8 · Registration statement for employee plansJan 30, 2026Offer documentSEC
DEF 14A · Proxy statementJan 2, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementDec 23, 2025Meeting noticeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 19, 2025Big-stake noticeSEC
8-K · Current reportDec 17, 2025Current reportSEC
424B3 · ProspectusDec 16, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 16, 2025Other filingsSEC
CORRESP · Letter to the SECDec 12, 2025Other filingsSEC
S-1 · Registration statementDec 10, 2025Offer documentSEC
S-8 · Registration statement for employee plansDec 1, 2025Offer documentSEC
8-K · Current reportNov 25, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
8-K · Current reportNov 12, 2025ResultsSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
RW · Request to withdraw a registrationOct 14, 2025Other filingsSEC
8-K · Current reportOct 3, 2025Current reportSEC
S-1 · Registration statementAug 29, 2025Offer documentSEC
8-K · Current reportAug 29, 2025Material contractSEC
SCHEDULE 13G · Big-stake noticeAug 20, 2025Big-stake noticeSEC
8-K · Current reportAug 20, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
8-K · Current reportAug 11, 2025ResultsSEC
10-Q · Quarterly reportAug 11, 2025Quarterly reportSEC
424B3 · ProspectusJul 24, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 24, 2025Other filingsSEC
CORRESP · Letter to the SECJul 22, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 22, 2025Other filingsSEC
S-1 · Registration statementJul 18, 2025Offer documentSEC
8-K · Current reportJul 3, 2025Meeting outcomeSEC
8-K · Current reportJun 23, 2025Meeting outcomeSEC
8-K · Current reportJun 18, 2025Current reportSEC
DEFA14A · Additional proxy materialJun 18, 2025Meeting noticeSEC
8-K · Current reportJun 17, 2025Current reportSEC
ARS · Annual report to shareholdersMay 29, 2025Annual reportSEC
DEF 14A · Proxy statementMay 29, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementMay 19, 2025Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 14, 2025Big-stake noticeSEC
8-K · Current reportMay 13, 2025ResultsSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
424B5 · ProspectusMay 2, 2025Offer documentSEC
8-K · Current reportMay 2, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveMay 2, 2025Other filingsSEC
CORRESP · Letter to the SECApr 30, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 30, 2025Other filingsSEC
S-1 · Registration statementApr 28, 2025Offer documentSEC
8-K · Current reportApr 24, 2025Material contractSEC
UPLOAD · Letter from the SECApr 9, 2025Other filingsSEC
CORRESP · Letter to the SECApr 7, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 31, 2025Other filingsSEC
DRS · Draft registration statementMar 5, 2025Offer documentSEC
8-K · Current reportFeb 24, 2025ResultsSEC
10-K · Annual reportFeb 24, 2025Annual reportSEC
8-K · Current reportFeb 20, 2025Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
8-K · Current reportFeb 6, 2025Material contractSEC
8-K · Current reportFeb 6, 2025Material contractSEC
424B5 · ProspectusFeb 5, 2025Offer documentSEC
8-K · Current reportJan 16, 2025Material contractSEC
424B5 · ProspectusJan 16, 2025Offer documentSEC
424B3 · ProspectusJan 14, 2025Offer documentSEC
DEFA14A · Additional proxy materialJan 14, 2025Meeting noticeSEC
DEF 14A · Proxy statementJan 14, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementJan 3, 2025Meeting noticeSEC
8-K · Current reportNov 26, 2024Meeting outcomeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
8-K · Current reportNov 12, 2024ResultsSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedNov 6, 2024Big-stake noticeSEC
ARS · Annual report to shareholdersOct 9, 2024Annual reportSEC
DEF 14A · Proxy statementOct 9, 2024Meeting noticeSEC
144 · Notice of proposed saleSep 16, 2024Other filingsSEC
8-K · Current reportAug 12, 2024ResultsSEC
10-Q · Quarterly reportAug 12, 2024Quarterly reportSEC
SC 13D/A · Big-stake notice, amendedAug 2, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeAug 1, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJul 29, 2024Big-stake noticeSEC
8-K · Current reportJul 26, 2024Material contractSEC
424B5 · ProspectusJul 25, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 24, 2024Other filingsSEC
CORRESP · Letter to the SECJul 23, 2024Other filingsSEC
CORRESP · Letter to the SECJul 23, 2024Other filingsSEC
S-1/A · Registration statement, amendedJul 19, 2024Offer documentSEC
FWP · Free writing prospectusJul 15, 2024Offer documentSEC
S-1 · Registration statementJul 15, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 9, 2024Other filingsSEC
S-3/A · Registration statement, amendedJul 5, 2024Offer documentSEC
CORRESP · Letter to the SECJul 5, 2024Other filingsSEC
8-K · Current reportJul 3, 2024Meeting outcomeSEC
UPLOAD · Letter from the SECJul 2, 2024Other filingsSEC
S-3 · Registration statementJul 1, 2024Offer documentSEC
UPLOAD · Letter from the SECJun 18, 2024Other filingsSEC
DRS · Draft registration statementJun 14, 2024Offer documentSEC
DEF 14A · Proxy statementJun 3, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementMay 24, 2024Meeting noticeSEC
8-K · Current reportMay 9, 2024ResultsSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
10-K/A · Annual report, amendedApr 29, 2024Annual reportSEC
4 · Change in ownershipApr 1, 2024Insider tradeSEC
8-K · Current reportMar 15, 2024ResultsSEC
10-K · Annual reportMar 15, 2024Annual reportSEC
SC 13G · Big-stake noticeFeb 27, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 26, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 26, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 15, 2024Insider tradeSEC
4 · Change in ownershipFeb 15, 2024Insider tradeSEC
4 · Change in ownershipFeb 15, 2024Insider tradeSEC
424B5 · ProspectusFeb 15, 2024Offer documentSEC
8-K · Current reportFeb 14, 2024Material contractSEC
EFFECT · Notice that a registration is effectiveFeb 14, 2024Other filingsSEC
SC 13G · Big-stake noticeFeb 12, 2024Big-stake noticeSEC
CORRESP · Letter to the SECFeb 9, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 9, 2024Other filingsSEC
FWP · Free writing prospectusJan 19, 2024Offer documentSEC
S-1 · Registration statementJan 19, 2024Offer documentSEC
UPLOAD · Letter from the SECJan 11, 2024Other filingsSEC
DRS · Draft registration statementJan 4, 2024Offer documentSEC
S-8 · Registration statement for employee plansDec 4, 2023Offer documentSEC
8-K · Current reportNov 14, 2023ResultsSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
4 · Change in ownershipOct 3, 2023Insider tradeSEC
4 · Change in ownershipOct 3, 2023Insider tradeSEC
4 · Change in ownershipOct 3, 2023Insider tradeSEC
4 · Change in ownershipOct 3, 2023Insider tradeSEC
8-K · Current reportAug 14, 2023ResultsSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
4 · Change in ownershipJul 24, 2023Insider tradeSEC
3 · Initial statement of ownershipJul 24, 2023Insider tradeSEC
8-K · Current reportJul 11, 2023Management or board changeSEC
8-K · Current reportJul 7, 2023Current reportSEC
SC 13D · Big-stake noticeJul 3, 2023Big-stake noticeSEC
4/A · Change in ownership, amendedJun 29, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
4 · Change in ownershipJun 23, 2023Insider tradeSEC
8-K · Current reportJun 21, 2023Material contractSEC
424B4 · ProspectusJun 21, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 16, 2023Other filingsSEC
3 · Initial statement of ownershipJun 15, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 15, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 15, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 15, 2023Insider tradeSEC
3 · Initial statement of ownershipJun 15, 2023Insider tradeSEC

This page holds 200 of 242 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Azitra Inc’s releases · as of Nov 12, 2026

Common shares
6,060,435
Fully diluted
6,060,435

Fully diluted

LineSharesAs of
Common shares6,060,435Nov 12, 2026

Share count over time

CountShares
Nov 12, 20266,060,435
Oct 16, 2026

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Dauntless Investment Group, LLC12.6MUS$1.73MSep 30, 2026
Stonepine Capital Management, LLC5.23MUS$719KSep 30, 2026
Nantahala Capital Management, LLC2.21MUS$305KSep 30, 2026
Vanguard322KUS$44,452Sep 30, 2026
Susquehanna238KUS$32,783Sep 30, 2026
Jane Street222KUS$30,599Sep 30, 2026
Hrt Financial LP161KUS$22,000Sep 30, 2026
Geode Capital95,409US$13,127Sep 30, 2026
StoneX Group Inc.84,671US$12,360Sep 30, 2026
Virtu Financial LLC67,259US$9,000Sep 30, 2026
All 20 holders
HolderSharesValueAs of
Tower Research Capital LLC (TRC)52,604US$7,238Sep 30, 2026
UBS37,855US$5,224Sep 30, 2026
Two Sigma21,916US$3,016Sep 30, 2026
Flow Traders U.S. LLC21,750US$3,000Sep 30, 2026
Corient Private Wealth LP14,451US$1,989Sep 30, 2026
XTX Topco Ltd14,064US$1,935Sep 30, 2026
Citigroup Inc2,526US$348Sep 30, 2026
Robinhood Markets, Inc.639US$87Sep 30, 2026
Strategic Financial Concepts, LLC197US$27Sep 30, 2026
Barclays7US$1Sep 30, 2026

Funds

HolderSharesValueAs of
Fidelity Extended Market Index Fund359KUS$82,575May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Nantahala Capital Management, LLC9.99%6.48MJun 30, 2026Schedule 13G
Salva Francisco D.9.99%5.42MJun 16, 2026Schedule 13D
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP8.40%5.45MJun 30, 2026Schedule 13G
Young Pharmaceuticals, Inc.5.22%316KNov 6, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Barbara Ryan
Other companies: Indivior Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); Supernus Pharmaceuticals, Inc. (Director · Since at least Jan 1, 2026); MiNK Therapeutics, Inc. (Director · Since at least Oct 13, 2021); INVO Fertility, Inc. (Director · Since at least Sep 14, 2020)
Director · Since at least Jun 15, 2023
Francisco Salva
Other companies: Vincerx Pharma Inc (Director · May 13, 2021 – May 23, 2024 · Past)
President and CEO · Since at least Jun 15, 2023
Norman Staskey
Other companies: VivoSim Labs, Inc. (Chief Financial Officer · Since at least Dec 30, 2024)
Chief Financial Officer · Since at least Jun 15, 2023
Travis Whitfill
Other companies: IN8bio, Inc. (Director · Jul 29, 2021 – Dec 19, 2024 · Past)
Cofounder and Chief Operating Officer · Since at least Jun 15, 2023
Andrew McClaryDirector · Jun 15, 2023 – Jun 23, 2023 · Past
John R. SchroerDirector · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Azitra Inc.